After careful consideration and concern for public health matters which are rapidly changing, The Cure Parkinson’s Trust has decided to reschedule the Spring Research Update Meeting on 24th March.

We apologise for any inconvenience this may cause but hope you would be able to join us for our next meeting, the date of which will be announced soon.


‘Ambroxol – Old drug, new future’

2.30 pm    Arrival and registration

3.00 pm    Welcome – Helen Matthews, Deputy CEO, The Cure Parkinson’s Trust (CPT)

3.05 pm    Ambroxol in context:  What is ambroxol? Dr Simon Stott, Deputy Director of Research, CPT

3.20 pm    The ambroxol trial results – Dr Stephen Mullin, Clinical Neuropsychologist, University of Plymouth

3.45 pm    The ambroxol trial – a participant’s perspective - Bev Maydon

4.00 pm    Q & A

4.20 pm Tea/coffee break

4.50 pm The regulatory pathway: ownership of the drug and is this a barrier to developing a treatment? – Dr Joy Duffen, CPT

5.05 pm What next - finding the dose and why this step is important? – Dr Marco Toffoli, UCL,

5.20 pm What should phase III look like? Who should take part? - Dr Stephen Mullin

5.45 pm Other International Linked Clinical Trials candidates – Dr Richard Wyse –   Director of Research, CPT

6.05 pm Q & A

6.20 pm Concluding comments – meeting close

6.30 pm Drinks reception (light snacks will be served)

Please note: timings may alter slightly on the day and speakers may change due to unforeseen circumstances. 

Booking for this event has now closed.